In line with our mission to bring only the most critical news and analysis to pharma readers like yourself, we've partnered with our friends at BioWorld Today on a special two-part editorial series. Part I runs today; John Carroll introduces it in the space above. Catch Part II in FiercePharma on March 19.
Drop me a line if you have ideas on how we can best continue satisfying your daily diet of pharma news on email, Twitter, or LinkedIn, and most of all--thanks for your readership. – Arsalan Arif, publisher